Evaluating High-risk Clinicopathological Indicators in GIST
Evaluating High-risk Clinicopathological Indicators in GIST
In this study, we analyzed several "very high-risk" factors in high-risk group of GIST patients after R0 resection. Serosal invasion appears to improve the modified NIH criteria and predicts an unfavorable outcome in high-risk GIST patients, with or without imatinib treatment. Our study demonstrated the possibility of personalized medical strategy for different GISTs by sub-dividing high-risk patients.
Conclusions
In this study, we analyzed several "very high-risk" factors in high-risk group of GIST patients after R0 resection. Serosal invasion appears to improve the modified NIH criteria and predicts an unfavorable outcome in high-risk GIST patients, with or without imatinib treatment. Our study demonstrated the possibility of personalized medical strategy for different GISTs by sub-dividing high-risk patients.